← Back to directory

Stephen Clarke

Researcher Next ID · RN-022303

Researcher · Medicine

The University of Sydney

Sydney, New Zealand

Not currently recruitingFunding unknown
Works count
713
Citation count
31,327
H-index
81
i10-index
339

Research interests

Medicine
Colorectal Cancer Treatments and Studies
Lung Cancer Treatments and Mutations
Cancer Treatment and Pharmacology
Inflammatory Biomarkers in Disease Prognosis
Lung Cancer Research Studies

Publications

  • Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

    Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.020

  • Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30621-6

  • First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30457-6

  • Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.63.0905

  • Cancer-related inflammation and treatment effectiveness

    The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70263-3

  • The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

    Critical Reviews in Oncology/Hematology · 2013 · https://doi.org/10.1016/j.critrevonc.2013.03.010

  • Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70509-0

  • Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review

    The Oncologist · 2012 · https://doi.org/10.1634/theoncologist.2012-0223

  • Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial

    Supportive Care in Cancer · 2011 · https://doi.org/10.1007/s00520-011-1209-6

  • Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial

    Annals of Oncology · 2009 · https://doi.org/10.1093/annonc/mdp479

  • Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

    Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.14.9898

  • Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

    Drug Metabolism and Disposition · 2008 · https://doi.org/10.1124/dmd.107.018747

Current projects

    No projects listed.